Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00361_DB01167_nanopub.RArOAxd1i6A5ifK_0xsfRlhIEtok5aomQQgFoi6DKd94U#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00361_DB01167 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00361_DB01167 label "DDI between Vinorelbine and Itraconazole - Itraconazole, a strong CYP3A4 and p-glycoprotein inhibitor, may increase the serum concentration of Vinorelbine by decreasing its metabolism and/or increasing its efflux. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Itraconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00361_DB01167]" assertion.
- drugbank_resource:DB00361_DB01167 identifier "drugbank_resource:DB00361_DB01167" assertion.
- drugbank_resource:DB00361_DB01167 title "DDI between Vinorelbine and Itraconazole - Itraconazole, a strong CYP3A4 and p-glycoprotein inhibitor, may increase the serum concentration of Vinorelbine by decreasing its metabolism and/or increasing its efflux. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Itraconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00361 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00361_DB01167 assertion.
- drugbank:DB01167 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00361_DB01167 assertion.